The demand for robust patient data and real-world evidence (RWE) continues to grow as regulators, payers, researchers, and physicians look to answer questions throughout the entire lifecycle of a drug. While patient registries are an important data source, traditional means of data collection greatly limit the types and amounts of information ...
read more